Drug‐Induced Liver Injury by Selective Androgenic Receptor Modulators

Drug‐Induced Liver Injury by Selective Androgenic Receptor Modulators / Joan Ericka Flores, Shivakumar Chitturi, Sarah Walker. - (Hepatology Communications 4 (2020) 3 (March) ; p. 450-452).

  • DOI: 10.1002/hep4.1456.
  • PMCID: PMC7049679.
  • PMID: 32140660

Abstract

Selective androgenic receptor modulators (SARMs) have not been approved by the U.S. Food and Drug Administration but they are heavily promoted as alternatives to androgenic anabolic steroids. We present two cases of liver injury associated with SARMs.

Original document

Parameters

Science
Case report
Date
3 January 2020
People
Chitturi, Shivakumar
Flores, Joan Ericka
Walker, Sarah
Country
Australia
Language
English
Other organisations
Australian National University (ANU)
Canberra Hospital
Doping classes
S1. Anabolic Agents
Substances
Enobosarm (ostarine)
LGD-4033 (ligandrol)
RAD140
Selective androgen receptor modulators (SARMs)
Medical terms
Health effects
Kidney / liver disease
Various
Supplements
Document category
Scientific article
Document type
Pdf file
Date generated
18 May 2020
Date of last modification
1 December 2021
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin